Epstein-Barr Virus Antibodies to Differentiate MS From Other Neuroinflammatory Diseases
Neurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Paulus Rommer about the evolving understanding of Epstein-Barr virus (EBV) and its role in multiple sclerosis (MS), including recent research on EBV antibodies as diagnostic markers and potential therapeutic targets. Read the related article in . Disclosures can be found at .
info_outline
Trends in Head CT Use in US Emergency Department Patients
Neurology® Podcast
Dr. Andy Southerland talks with Dr. Layne Dylla about the trends in head CT use in US emergency departments from 2007 to 2022, highlighting disparities, regional variations, and the potential role of AI in optimizing imaging decisions. Read the related article in . Disclosures can be found at .
info_outline
A Discussion with Dr. Alison Christy: 2026 Ted Burns Humanism in Neurology Award Winner
Neurology® Podcast
Dr. Stacey Clardy talks with Dr. Alison Christy, the recipient of the 2026 Ted Burns Humanism in Neurology Award, about her inspiring career, innovative approaches to neurology education, and how she fosters compassion and creativity in medicine. Disclosures can be found at .
info_outline
2026 AAN President's Award Recipient - Dr. Walter J. Koroshetz
Neurology® Podcast
Dr. Greg Cooper talks with Dr. Walter J. Koroshetz about his journey from a childhood fascination with the brain to leading the NINDS and his enduring commitment to advocacy, scientific rigor, and patient care. Read more about the . Disclosures can be found at .
info_outline
A Path to Preventing Cognitive Impairment Due to Alzheimer Disease
Neurology® Podcast
Dr. Greg Cooper talks with Dr. Eric Reiman about emerging antibody therapies for preclinical Alzheimer disease and the clinical, regulatory, and equity considerations shaping prevention trials and future care. Read the related article in . Disclosures can be found at .
info_outline
History of Letters to the Editor
Neurology® Podcast
As we celebrate the 75th anniversary of Neurology®, Dr. Jeff Ratliff talks with Drs. Steven Galetta and Robert Griggs about the history and evolution of the Letters to the Editor section. Join the conversation by visiting the . Disclosures can be found at .
info_outline
Landmark Clinical Trials Shaping Patient Care
Neurology® Podcast
Dr. H.E. Hinson talks with Dr. Vijay Ramanan about the upcoming Clinical Trials Plenary Session at the AAN Annual Meeting and the landmark studies shaping neurologic care. For more information about this event, . Disclosures can be found at .
info_outline
Antiseizure Medication Dosing Strategy During Pregnancy and Early Postpartum in Women With Epilepsy in MONEAD
Neurology® Podcast
Dr. Derek Stitt talks with Dr. Page B. Pennell about antiseizure medication management during pregnancy and postpartum, based on the MONEAD study. Read the related article in . Disclosures can be found at .
info_outline
April 2026 Recall: Topics on Vascular Neurology
Neurology® Podcast
The April 2026 recall features four previously posted episodes on vascular neurology. The episode begins with Dr. Shyam Prabhakaran discussing the 2026 AHA/ASA guidelines for the early management of acute ischemic stroke. The episode continues with Dr. Seemant Chaturvedi discussing the latest findings from the 2026 International Stroke Conference. In the third episode, Dr. Amrou Sarraj discusses the importance of understanding anesthesia's impact on patient outcomes, the implications for clinical practice, and future research directions in stroke treatment. The episode concludes with Dr. Urs...
info_outline
FDA Revises Trial Requirements for Drug and Medical Product Approval
Neurology® Podcast
Dr. Justin Abbatemarco talks with Lizzy Lawrence about the FDA’s shift toward single-trial drug approvals and its implications for neurology, rare diseases, and broader effects on drug approval standards and healthcare access. Read the related article on . Disclosures can be found at .
info_outlineThe September 2023 Neurology Recall showcases five dynamic interviews about ALS. The episode begins with a discussion about the strategic plan for ALS from the NINDS with Dr. Walter Korshetz. This episode features conversations with Drs. Ruben P.A. van Eijk-3 and Jordi van Unnik on simulation based interim analysis of ALS clinical trials followed by an interview with Dr. Emily Plowman on respiratory strength training (RST) programs in individuals with ALS. The episode continues with an interview with Dr. Suma Babu on the approved treatment for ALS associated with a mutation in the SOD1 gene. This month's Recall concludes with a conversation with Dr. Ajay Sampat on his story of being a neurologist diagnosed with ALS.
Related Articles:
- Development and Evaluation of a Simulation-Based Algorithm to Optimize the Planning of Interim Analyses for Clinical Trials in ALS
- Respiratory Strength Training in Amyotrophic Lateral Sclerosis
- FDA Approves Treatment of Amyotrophic Lateral Sclerosis Associated With a Mutation in the SOD1 Gene
Related Podcast:
- The ALS Strategic Plan from NINDS
- Simulation-Based Planning of ALS Trials
- Respiratory Strength Training in ALS
- FDA Approved Therapy for SOD1 Associated ALS
- A Neurologist’s Experience as a Patient with ALS
Visit NPUb.org/Podcast for associated article links.
Disclosures can be found at Neurology.org.